---
title: "A2A PHARMACEUTICALS, INC. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/aded4ab2-0a71-50ec-a2b7-b94a0dfcf833
json: https://whiteintel.dev/api/public/dossier/aded4ab2-0a71-50ec-a2b7-b94a0dfcf833
identifier: sec:0001859061
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# A2A PHARMACEUTICALS, INC.

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001859061`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/aded4ab2-0a71-50ec-a2b7-b94a0dfcf833  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/aded4ab2-0a71-50ec-a2b7-b94a0dfcf833  

## Ownership & control

### Holdings / subsidiaries

- **Biomea Fusion, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/7153dcb9-fee1-5302-b53c-4cede9b8d744

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **A2A PHARMACEUTICALS, INC.**. Human view: https://whiteintel.dev/entity/aded4ab2-0a71-50ec-a2b7-b94a0dfcf833 · Structured JSON: https://whiteintel.dev/api/public/dossier/aded4ab2-0a71-50ec-a2b7-b94a0dfcf833._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._